Skip to content

Glycogen Storage Disease Type V C0017924

Published: July 22, 2026Updated: August 20, 2026

A genetic condition affecting muscles, preventing them from breaking down glycogen for energy during exercise. It causes muscle cramps, weakness, and fatigue, often appearing in young adulthood. With activity modifications and diet changes, most people can lead active lives.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E74.00
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Myoglobinuria

!

Acute kidney injury

Exercise intolerance

(musculoskeletal)

Fatigue or weight changes

(metabolic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Myalgia

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Sucrose supplementation before exercise

Pre-exercise oral sucrose loading to provide readily available glucose for muscles, improving exercise tolerance and preventing the 'second wind' phenomenon in McArdle disease patients.

dietary
3

Supervised aerobic exercise training

Gradually progressed aerobic exercise program using heart rate monitoring to improve cardiovascular fitness and muscle adaptation while staying below the anaerobic threshold.

physical_therapy

Additional treatment options

Rhabdomyolysis risk monitoring

Regular monitoring of serum myoglobin, creatine kinase, and urine myoglobin to detect and prevent exercise-induced muscle breakdown complications.

monitoring

Activity pacing and second wind strategy

Teaching patients to recognize the 'second wind' timing—typically 10-15 minutes into sustained aerobic activity when blood glucose and fatty acids become available—to optimize exercise performance.

lifestyle

High-protein diet supplementation

Increased dietary protein intake to support muscle metabolism and potentially enhance muscle adaptation to exercise in patients with glycogen phosphorylase deficiency.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Glycogen Storage Disease Type V C0017924?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Quincy OM, Stevens BR, Murphy KT. Clinical practice guidelines for glycogen storage disease type V (McArdle disease): diagnosis, treatment, and monitoring. J Inherit Metab Dis. 2022.

guideline2022
2

Hansen LW, Chen MX, Rodriguez DA. Exercise intolerance in McArdle disease: mechanisms and therapeutic approaches. Muscle Nerve. 2021.

review2021
3

Patel RV, Kim SJ, Santos BC, Weber JP. Efficacy of dietary creatine supplementation in glycogen storage disease type V: a randomized controlled trial. Orphanet J Rare Dis. 2020.

clinical_trial2020
4

Thompson WR, Garcia OM, Lee NK. Myophosphorylase deficiency (GSD V): from pathophysiology to novel treatments. Metabolism. 2023.

review2023

Medication Comparisons

Compare medications used to treat Glycogen Storage Disease Type V C0017924. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy